Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Voll Degradable Shoulder Spacer FIH Study

NCT: NCT07208448 · RECRUITING

NCT IDNCT07208448
StatusRECRUITING
Start Date2025-12-09
Completion2027-12-31
SponsorVoll Medical Technologies Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Frequently Asked Questions

What is Voll Degradable Shoulder Spacer FIH Study?

Voll Degradable Shoulder Spacer FIH Study is a clinical trial registered under NCT07208448. Current status: RECRUITING.

What is the status of NCT07208448?

The current status of NCT07208448 (Voll Degradable Shoulder Spacer FIH Study) is: RECRUITING.

When did Voll Degradable Shoulder Spacer FIH Study start?

Voll Degradable Shoulder Spacer FIH Study started on 2025-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑